Neil Cashman
Founder at PROMIS NEUROSCIENCES, INC.
Net worth: 219 499 $ as of 2024-03-30
Profile
Neil R.
Cashman is the founder of Caprion Proteomics, Inc. (founded in 2000) and ProMIS Neurosciences, Inc. (founded in 2004).
He is currently the Director-UBC ALS Centre & Professor at the University of British Columbia (since 2005), Director-ALS Clinic at Vancouver General Hospital (since 2005), Director at ALS Society of British Columbia, and Director at Alberta Innovates BioSolutions.
In the past, he was the Director-Neuromuscular Clinic at Sunnybrook & Womens Foundation and a Professor at the University of Toronto (1998-2005).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-10-25 | 114,921 ( 0.61% ) | 219 499 $ | 2024-03-30 |
Neil Cashman active positions
| Companies | Position | Start |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Founder | 2004-01-22 |
| University of British Columbia | Corporate Officer/Principal | 2005-06-30 |
| Vancouver General Hospital | Corporate Officer/Principal | 2005-06-30 |
Alberta Innovates BioSolutions
 Alberta Innovates BioSolutions BiotechnologyHealth Technology Alberta Innovates BioSolutions develops bioindustrial technologies and natural products. It delivers on the potential of agriculture and forestry in areas such as: value chain sustainability, advancing the biorefinery, quality food for health, industry challenges and emerging opportunities, and prion and prion-like protein misfolding diseases. The firm aims to be a global gateway and resource for bio-based research, talent, investment and solutions. The company was founded on January 1, 2010 and is headquartered in Edmonton, Canada. | Director/Board Member | - |
ALS Society of British Columbia
 ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services ALS Society of British Columbia provides direct support to ALS patients, along with their families and caregivers. The firm's services include equipment loan program, patient transportation support, support groups, care connections program, and mobile clinics. The company is headquartered in Richmond, Canada. | Director/Board Member | - |
Former positions of Neil Cashman
| Companies | Position | End |
|---|---|---|
| University of Toronto | Corporate Officer/Principal | 2004-12-31 |
Caprion Proteomics, Inc.
 Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Founder | - |
| Sunnybrook & Womens Foundation | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Private companies | 5 |
|---|---|
| Sunnybrook & Womens Foundation | |
| Vancouver General Hospital | |
ALS Society of British Columbia
ALS Society of British Columbia Miscellaneous Commercial ServicesCommercial Services ALS Society of British Columbia provides direct support to ALS patients, along with their families and caregivers. The firm's services include equipment loan program, patient transportation support, support groups, care connections program, and mobile clinics. The company is headquartered in Richmond, Canada. | Commercial Services |
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Alberta Innovates BioSolutions develops bioindustrial technologies and natural products. It delivers on the potential of agriculture and forestry in areas such as: value chain sustainability, advancing the biorefinery, quality food for health, industry challenges and emerging opportunities, and prion and prion-like protein misfolding diseases. The firm aims to be a global gateway and resource for bio-based research, talent, investment and solutions. The company was founded on January 1, 2010 and is headquartered in Edmonton, Canada. | Health Technology |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Health Technology |
- Stock Market
- Insiders
- Neil Cashman
